ALIVE
AzimiLide post-Infarct surVival Evaluation

Purpose
To evaluate the potential of azimilide for decreasing all-cause mortality in a target population at high risk of SCD

References
The trial design has not been published

Voltar

Apoio: Libbs Farmacêutica Farmacêutica